Kingdom supplies pet‑food, treat and supplement manufacturers with natural, clinically validated multi‑strain microbial ingredients that improve oral health, skin/coat condition, and immune performance in dogs. Leveraging a biobank of over 10,000 food‑derived strains, AI‑driven combinatorial design, and heat‑ and moisture‑stable live‑culture or fermentate formats, the company delivers AAFCO‑compliant, non‑GMO, clean‑label solutions with end‑to‑end development support.
Funding
$25M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SCFounders
Product
Problem
Pet food and supplement brands often rely on synthetic additives or single‑strain probiotics that provide limited functional benefits, making it difficult to address specific health challenges such as oral disease, itching, or immune support in a clean‑label, scientifically backed way.
Solution
Kingdom leverages a proprietary platform that isolates tens of thousands of naturally occurring microbial strains from food sources, characterizes them with genomics, metabolomics, and high‑throughput phenotyping, and then uses AI‑driven combinatorial design to assemble multi‑strain live cultures or fermentates—its Superculture® ingredients. These ingredients are delivered as stable, heat‑ and moisture‑resistant formulations that can be incorporated directly into pet foods, treats, or supplements. The company offers custom development cycles of 3–6 months, moving from benchtop validation through pilot and commercial‑scale production, and provides end‑to‑end technical support to ensure product performance. Two flagship ingredients—Pet Oral (clinically validated for plaque reduction and breath freshening) and Pet Immune (clinically validated for itch reduction and skin/coat health)—demonstrate the platform’s ability to generate measurable health outcomes. All ingredients meet AAFCO definitions, are non‑GMO, and are positioned as clean‑label, natural solutions that outperform conventional additives.
Target Audience
Primary customers are pet‑food manufacturers, treat producers, and supplement brands that require natural, clinically proven functional ingredients to enhance oral health, skin/coat condition, or immune performance in dogs (and potentially cats).
Features
- A curated biobank of >10 000 food‑derived microbial strains with full genomic and metabolic annotation.
- High‑throughput isolation and phenotypic screening pipelines powered by automated liquid handling and machine‑learning analytics.
- AI‑enabled combinatorial design engine that predicts emergent functional properties across multi‑strain assemblies.
- Proprietary analytical chemistry and microscopy workflows that quantify bioactive metabolites and ensure batch‑to‑batch consistency.
- Live‑culture and fermentate formats engineered for thermal stability, pressure resistance, and moisture tolerance, compatible with standard pet‑food processing.
- Clinically validated efficacy demonstrated in double‑blind trials for oral health (Plaque Index reduction) and immune health (itch score improvement).
- Full regulatory compliance with AAFCO, non‑GMO certification, and clean‑label ingredient declarations.
- Scalable manufacturing infrastructure delivering commercial‑scale supply with real‑time quality monitoring and traceability.